ArticleEMBO molecular medicine2026
Micrometastasis-derived models enable drug testing for early-stage, high-risk melanoma patients.
Kathrin Weidele et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it